155 related articles for article (PubMed ID: 24996454)
1. Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.
Mavroidis P; Giantsoudis D; Awan MJ; Nijkamp J; Rasch CR; Duppen JC; Thomas CR; Okunieff P; Jones WE; Kachnic LA; Papanikolaou N; Fuller CD;
Radiother Oncol; 2014 Sep; 112(3):418-24. PubMed ID: 24996454
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.
Fuller CD; Nijkamp J; Duppen JC; Rasch CR; Thomas CR; Wang SJ; Okunieff P; Jones WE; Baseman D; Patel S; Demandante CG; Harris AM; Smith BD; Katz AW; McGann C; Harper JL; Chang DT; Smalley S; Marshall DT; Goodman KA; Papanikolaou N; Kachnic LA;
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):481-9. PubMed ID: 20400244
[TBL] [Abstract][Full Text] [Related]
3. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
[TBL] [Abstract][Full Text] [Related]
4. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
Myerson RJ; Garofalo MC; El Naqa I; Abrams RA; Apte A; Bosch WR; Das P; Gunderson LL; Hong TS; Kim JJ; Willett CG; Kachnic LA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):824-30. PubMed ID: 19117696
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case.
Lobefalo F; Bignardi M; Reggiori G; Tozzi A; Tomatis S; Alongi F; Fogliata A; Gaudino A; Navarria P; Cozzi L; Scorsetti M; Mancosu P
Radiat Oncol; 2013 Jul; 8():176. PubMed ID: 23837942
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
7. Dose-volume and radiobiological dependence on the calculation grid size in prostate VMAT planning.
Chow JCL; Jiang R
Med Dosim; 2018 Winter; 43(4):383-389. PubMed ID: 29373184
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.
Mok H; Crane CH; Palmer MB; Briere TM; Beddar S; Delclos ME; Krishnan S; Das P
Radiat Oncol; 2011 Jun; 6():63. PubMed ID: 21651775
[TBL] [Abstract][Full Text] [Related]
9. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
10. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel.
Engels B; De Ridder M; Tournel K; Sermeus A; De Coninck P; Verellen D; Storme GA
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1476-80. PubMed ID: 19231097
[TBL] [Abstract][Full Text] [Related]
11. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
[TBL] [Abstract][Full Text] [Related]
12. Development of a consensus-based delineation guideline for locally recurrent rectal cancer.
Piqeur F; Hupkens BJP; Nordkamp S; Witte MG; Meijnen P; Ceha HM; Berbee M; Dieters M; Heyman S; Valdman A; Nilsson MP; Nederend J; Rutten HJT; Burger JWA; Marijnen CAM; Peulen HMU
Radiother Oncol; 2022 Dec; 177():214-221. PubMed ID: 36410547
[TBL] [Abstract][Full Text] [Related]
13. Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging.
Krengli M; Cannillo B; Turri L; Bagnasacco P; Berretta L; Ferrara T; Galliano M; Gribaudo S; Melano A; Munoz F; Sciacero P; Tseroni V; Bassi MC; Brambilla M; Inglese E
Technol Cancer Res Treat; 2010 Aug; 9(4):393-8. PubMed ID: 20626204
[TBL] [Abstract][Full Text] [Related]
14. The effect of slice thickness on target and organs at risk volumes, dosimetric coverage and radiobiological impact in IMRT planning.
Srivastava SP; Cheng CW; Das IJ
Clin Transl Oncol; 2016 May; 18(5):469-79. PubMed ID: 26311077
[TBL] [Abstract][Full Text] [Related]
15. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.
Baldini EH; Abrams RA; Bosch W; Roberge D; Haas RLM; Catton CN; Indelicato DJ; Olsen JR; Deville C; Chen YL; Finkelstein SE; DeLaney TF; Wang D
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1053-1059. PubMed ID: 26194680
[TBL] [Abstract][Full Text] [Related]
17. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Chang X; Deng W; Wang X; Zhou Z; Yang J; Guo W; Liu M; Qi X; Li L; Zhang K; Zhang M; Shi Y; Liu K; Zhao Y; Wang H; Yu Z; Zhang J; Wang L; Qiao X; Han C; Zhu S; Zhang R; Chen J; Hu C; Zhang F; Hou X; Pang Q; Zhang W; Li G; Lin H; Sun X; Ge X; Li C; Ge H; Li D; Wang Y; Lu N; Gao X; Qin S; Tian Y; Xiao Z
Radiat Oncol; 2021 Jun; 16(1):102. PubMed ID: 34107984
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
20. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
